Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 18.93 | 23.87 |
| PEG Ratio (TTM) | 1.10 | -0.15 |
| P/S Ratio (TTM) | 2.77 | 3.31 |
| P/B Ratio (TTM) | 2.44 | 4.32 |
| P/FCF Ratio (TTM) | 35.09 | 43.71 |
| Price to 5YR AVG Earnings Ratio | N/A | 79.63 |
| Price to 5YR AVG FCF Ratio | N/A | 39.32 |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 7.12% | 6.93% |
| ROE (TTM) | 17.32% | 14.27% |
| Net Profit Margin (TTM) | 14.30% | 13.36% |
| ROIC 5YR AVG | N/A | 14.16% |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 86.83% | 158.11% | N/A |
| Revenue | 47.70% | 140.85% | N/A |
| Net Income | 86.86% | 157.79% | N/A |
| Cash Flow | 176.72% | 199.47% | N/A |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.29 | 2.34 |
| Quick Ratio (TTM) | 0.43 | 1.62 |
| D/E Ratio (TTM) | 0.26 | 0.51 |
| Interest Coverage (TTM) | 3.86 | 9.87 |
| Piotroski F-Score | 6 | 8 |
| Altman Z-Score | 1.30 | 4.80 |
| LTL to 5YR AVG FCF | N/A | 5.68 |
| Shares Outstanding Growth 5YR AVG | N/A | 7.55% |